July 2, 2021
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study. The research, which sought to evaluate the difference in weight loss caused by the antidiabetic medications — both of which work to control […]
